RBC Capital initiated coverage of Icon (ICLR) with an Outperform rating and $263 price target Icon is among the largest of the global contract research organizations, helping its biopharma clients ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Icon ( (ICLR)) has issued an announcement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback